A citation-based method for searching scientific literature

Ugo Testa, Germana Castelli, Elvira Pelosi. Medicines (Basel) 2019
Times Cited: 27







List of co-cited articles
66 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
25

Genetics and biology of prostate cancer.
Guocan Wang, Di Zhao, Denise J Spring, Ronald A DePinho. Genes Dev 2018
137
18


Integrative genomic profiling of human prostate cancer.
Barry S Taylor, Nikolaus Schultz, Haley Hieronymus, Anuradha Gopalan, Yonghong Xiao, Brett S Carver, Vivek K Arora, Poorvi Kaushik, Ethan Cerami, Boris Reva,[...]. Cancer Cell 2010
18

Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
14

Epidemiology of Prostate Cancer.
Prashanth Rawla. World J Oncol 2019
450
14

Treatment of Advanced Prostate Cancer.
Min Yuen Teo, Dana E Rathkopf, Philip Kantoff. Annu Rev Med 2019
113
11


DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
11

Genomic hallmarks of localized, non-indolent prostate cancer.
Michael Fraser, Veronica Y Sabelnykova, Takafumi N Yamaguchi, Lawrence E Heisler, Julie Livingstone, Vincent Huang, Yu-Jia Shiah, Fouad Yousif, Xihui Lin, Andre P Masella,[...]. Nature 2017
289
11

Towards precision oncology in advanced prostate cancer.
Sheng-Yu Ku, Martin E Gleave, Himisha Beltran. Nat Rev Urol 2019
58
11

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
11

A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.
Nataly Stylianou, Melanie L Lehman, Chenwei Wang, Atefeh Taherian Fard, Anja Rockstroh, Ladan Fazli, Lidija Jovanovic, Micheal Ward, Martin C Sadowski, Abhishek S Kashyap,[...]. Oncogene 2019
35
7


Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-β inhibits established bone metastasis in a prostate cancer mouse model.
Zebin Hu, Janhavi Gupta, Zhenwei Zhang, Helen Gerseny, Arthur Berg, Yun Ju Chen, Zhiling Zhang, Hongyan Du, Charles B Brendler, Xianghui Xiao,[...]. Hum Gene Ther 2012
44
7


Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.
Qianben Wang, Wei Li, Yong Zhang, Xin Yuan, Kexin Xu, Jindan Yu, Zhong Chen, Rameen Beroukhim, Hongyun Wang, Mathieu Lupien,[...]. Cell 2009
639
7


CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Sreenivasa R Chinni, Sivasakthy Sivalogan, Zhong Dong, J Carlos Trindade Filho, Xiyun Deng, R Daniel Bonfil, Michael L Cher. Prostate 2006
195
7


Evidence for molecular differences in prostate cancer between African American and Caucasian men.
Francesca Khani, Juan Miguel Mosquera, Kyung Park, Mirjam Blattner, Catherine O'Reilly, Theresa Y MacDonald, Zhengming Chen, Abhishek Srivastava, Ashutosh K Tewari, Christopher E Barbieri,[...]. Clin Cancer Res 2014
102
7

Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.
Matthew L Freedman, Christopher A Haiman, Nick Patterson, Gavin J McDonald, Arti Tandon, Alicja Waliszewska, Kathryn Penney, Robert G Steen, Kristin Ardlie, Esther M John,[...]. Proc Natl Acad Sci U S A 2006
453
7

Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.
Wassim Abida, Joshua Armenia, Anuradha Gopalan, Ryan Brennan, Michael Walsh, David Barron, Daniel Danila, Dana Rathkopf, Michael Morris, Susan Slovin,[...]. JCO Precis Oncol 2017
165
7

Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss.
Johann S de Bono, Ugo De Giorgi, Daniel Nava Rodrigues, Christophe Massard, Sergio Bracarda, Albert Font, Jose Angel Arranz Arija, Kent C Shih, George Daniel Radavoi, Na Xu,[...]. Clin Cancer Res 2019
139
7

Punctuated evolution of prostate cancer genomes.
Sylvan C Baca, Davide Prandi, Michael S Lawrence, Juan Miguel Mosquera, Alessandro Romanel, Yotam Drier, Kyung Park, Naoki Kitabayashi, Theresa Y MacDonald, Mahmoud Ghandi,[...]. Cell 2013
747
7

N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.
Etienne Dardenne, Himisha Beltran, Matteo Benelli, Kaitlyn Gayvert, Adeline Berger, Loredana Puca, Joanna Cyrta, Andrea Sboner, Zohal Noorzad, Theresa MacDonald,[...]. Cancer Cell 2016
230
7

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
David C Wedge, Gunes Gundem, Thomas Mitchell, Dan J Woodcock, Inigo Martincorena, Mohammed Ghori, Jorge Zamora, Adam Butler, Hayley Whitaker, Zsofia Kote-Jarai,[...]. Nat Genet 2018
103
7

Monoclonal antibodies and prostate-specific membrane antigen.
Sam S Chang. Curr Opin Investig Drugs 2004
14
14

225Ac-PSMA-617 for Therapy of Prostate Cancer.
Clemens Kratochwil, Uwe Haberkorn, Frederik Lars Giesel. Semin Nucl Med 2020
31
7

Prostate-specific membrane antigen expression in normal and malignant human tissues.
D A Silver, I Pellicer, W R Fair, W D Heston, C Cordon-Cardo. Clin Cancer Res 1997
961
7

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer.
Alec Paschalis, Beshara Sheehan, Ruth Riisnaes, Daniel Nava Rodrigues, Bora Gurel, Claudia Bertan, Ana Ferreira, Maryou B K Lambros, George Seed, Wei Yuan,[...]. Eur Urol 2019
87
7

Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.
Michael C Haffner, Irmgard E Kronberger, Jeffrey S Ross, Christine E Sheehan, Matthias Zitt, Gilbert Mühlmann, Dietmar Ofner, Bettina Zelger, Christian Ensinger, Ximing J Yang,[...]. Hum Pathol 2009
141
7


Recent Advances in Prostate Cancer Treatment and Drug Discovery.
Ekaterina Nevedomskaya, Simon J Baumgart, Bernard Haendler. Int J Mol Sci 2018
93
7

δ-Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells.
Fabrizio Fontana, Roberta Manuela Moretti, Michela Raimondi, Monica Marzagalli, Giangiacomo Beretta, Patrizia Procacci, Patrizia Sartori, Marina Montagnani Marelli, Patrizia Limonta. Cell Prolif 2019
31
7


Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations.
E David Crawford, Axel Heidenreich, Nathan Lawrentschuk, Bertrand Tombal, Antonio C L Pompeo, Arturo Mendoza-Valdes, Kurt Miller, Frans M J Debruyne, Laurence Klotz. Prostate Cancer Prostatic Dis 2019
81
7

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
Elizabeth C Page, Elizabeth K Bancroft, Mark N Brook, Melissa Assel, Mona Hassan Al Battat, Sarah Thomas, Natalie Taylor, Anthony Chamberlain, Jennifer Pope, Holly Ni Raghallaigh,[...]. Eur Urol 2019
63
7

The oncogene ERG: a key factor in prostate cancer.
P Adamo, M R Ladomery. Oncogene 2016
105
7

PD-1/PD-L1 pathway inhibitors in advanced prostate cancer.
Pedro Isaacsson Velho, Emmanuel S Antonarakis. Expert Rev Clin Pharmacol 2018
47
7

Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Johann de Bono, Joaquin Mateo, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, Oliver Sartor, Neeraj Agarwal, David Olmos,[...]. N Engl J Med 2020
405
7

Role of Androgen Receptor in Prostate Cancer: A Review.
Kazutoshi Fujita, Norio Nonomura. World J Mens Health 2019
84
7

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Piper Nicolosi, Elisa Ledet, Shan Yang, Scott Michalski, Brandy Freschi, Erin O'Leary, Edward D Esplin, Robert L Nussbaum, Oliver Sartor. JAMA Oncol 2019
91
7

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
Rong Na, S Lilly Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz,[...]. Eur Urol 2017
163
7

Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance.
Peter Horak, Joachim Weischenfeldt, Gunhild von Amsberg, Burkhard Beyer, Andreas Schütte, Sebastian Uhrig, Laura Gieldon, Barbara Klink, Lars Feuerbach, Daniel Hübschmann,[...]. Cold Spring Harb Mol Case Stud 2019
17
11

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
699
7

The Epidemiology of Prostate Cancer.
Claire H Pernar, Ericka M Ebot, Kathryn M Wilson, Lorelei A Mucci. Cold Spring Harb Perspect Med 2018
167
7

The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.
Boris Y Shorning, Manisha S Dass, Matthew J Smalley, Helen B Pearson. Int J Mol Sci 2020
65
7

Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
Luca Braglia, Manuela Zavatti, Marco Vinceti, Alberto M Martelli, Sandra Marmiroli. Biochim Biophys Acta Mol Cell Res 2020
18
11

SPOP and cancer: a systematic review.
Alison Clark, Marieke Burleson. Am J Cancer Res 2020
15
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.